Kenneth MacArthur
Joined WhatDoTheyKnow in 2021
Send message to Kenneth MacArthur
Sign in to change password, subscriptions and more (Kenneth MacArthur only)
This person's Freedom of Information requests (approximately 64)
Non-publication of COVID-19 vaccine iDAPs - Decision-makers
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Refused.
Dear Mr MacArthur
Please find a response to your request for an internal review of FOI 21/794 attached.
Kind regards,
Chris
MHRA Customer Experience...
Permission to publish COVID-19 vaccine iDAPs
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Partially successful.
Dear Mr MacArthur
Please find a response to your request for an internal review of FOI 22/049 attached.
Kind regards,
Chris
MHRA Customer Experience...
Use of Novavax COVID-19 vaccine (Nuvaxovid) in Wales
Response by Welsh Government to Kenneth MacArthur on .
Information not held.
Dear Mr MacArthur,
Please find the attached letter which relates to your recent Freedom of Information request.
Kind Regards
Rhian
Rhian Cowley
Go...
Potential safety signals with COVID-19 vaccines
Request to Medicines and Healthcare Products Regulatory Agency by Kenneth MacArthur. Annotated by Chandra Singh on .
Refused.
Well, that was a surprise.
Suspected adverse reactions to COVID-19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Awaiting response.
Our Ref: FOI 22/735
Dear Kenneth MacArthur,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 6...
Advice on use of Novavax COVID-19 vaccine (Nuvaxovid)
Response by The Joint Committee on Vaccination and Immunisation to Kenneth MacArthur on .
Refused.
Dear Kenneth MacArthur,
Please find attached the UK Health Security Agency's response to your
request.
Yours sincerely,
Information Rights Team...
Patient group direction (PGD)/national protocol for Novavax Nuvaxovid COVID-19 vaccine
Response by UK Health Security Agency to Kenneth MacArthur on .
Information not held.
Dear Kenneth MacArthur,
Please find attached UKHSA's response to your request.
Yours sincerely,
Information Rights Team
UK Health Security Agency...
E-mails relating to Pfizer-BioNTech COVID-19 vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Refused.
Dear Mr MacArthur,
Thank you for your email.
Please attached the reply to your Internal review.
Kind Regards
MHRA Custo...
Suspected adverse reactions to COVID-19 vaccines
Request to Medicines and Healthcare Products Regulatory Agency by Kenneth MacArthur. Annotated by Jon Baylis on .
Refused.
The truth will come out sooner or later. The dishonesty surrounding the vaccines is disgusting.
Use of Novavax COVID-19 vaccine (Nuvaxovid) in Wales
Response by Welsh Government to Kenneth MacArthur on .
Information not held.
Dear Mr MacArthur,
Please find the attached letter which relates to your recent Freedom of Information request.
Kind Regards
Rhian
Rhian Cowley
G...
Use of Novavax COVID-19 vaccine (Nuvaxovid) in Northern Ireland
Response by Department of Health (Northern Ireland) to Kenneth MacArthur on .
Information not held.
Kenneth,
Please see attached, response to your request below.
Kind regards,
Joyce
Joyce McGrattan
Information Management Branch
Department of Healt...
Communications regarding Valneva COVID-19 vaccine
Response by Department of Health and Social Care to Kenneth MacArthur on .
Long overdue.
Dear Mr MacArthur
Thank you for your message. I'm sorry, but I do not know the reason for this discrepancy.
Yours sincerely
FOI team
Use of Novavax COVID-19 vaccine (Nuvaxovid) in Northern Ireland
Response by Department of Health (Northern Ireland) to Kenneth MacArthur on .
Information not held.
Kenneth,
Thank you for your request below.
I have checked with the relevant business areas in the Department and can confirm that the Department of H...
Use of Novavax COVID-19 vaccine (Nuvaxovid) in Scotland
Response by Scottish Government to Kenneth MacArthur on .
Refused.
Good afternoon Mr McArthur,
Thank you for your email of 06 May 2022 requesting clarification on the
following sentence:
"This advice has n...
Communications with MHRA/CHM regarding Valneva COVID-19 vaccine
Response by Department of Health and Social Care to Kenneth MacArthur on .
Refused.
Dear Mr MacArthur.
Please find attached the internal review outcome letter in respect of the
handling of FOI-1397171.
Yours sincerely,
Mr...
Immunological phenomena in connection with vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held.
Internal Review of FOI 21/1343
Dear Kenneth Macarthur,
Thank you for your follow-up reply and a request for an internal review.
We note th...
Communications with MHRA/CHM regarding Valneva COVID-19 vaccine
Response by Department of Health and Social Care to Kenneth MacArthur on .
Refused.
Dear Mr MacArthur,
Please find attached our response letter to the internal review of
FOI-1370154.
Once again, please accept our apologies for...
UK Intergovernmental Council
Refused.
The latest development along this line is here: https://www.gov.uk/government/publications/the-review-of-intergovernmental-relations
Potential EU-UK SPS agreement
Response by Department for Environment, Food and Rural Affairs to Kenneth MacArthur on .
Refused.
Dear Kenneth MacArthur,
Please find attached the response to your request for an internal review
of 2nd October for information on Potential EU-UK S...
E-mails relating to Novavax COVID-19 vaccine
Request to Medicines and Healthcare Products Regulatory Agency by Kenneth MacArthur. Annotated by Kenneth MacArthur on .
Refused.
Response provided here: https://www.whatdotheyknow.com/request/e_mails_relating_to_pfizer_biont#incoming-1929858
Pre-licensing consideration of antigenic imprinting following vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held.
Dear Kenneth MacArthur,
Thank you for your email.
We have nothing further to add to our previous response.
Kind regards,
MHRA C...
Antigenic imprinting following vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held.
Dear Mr MacArthur
Regarding your email of 28 October 2021, where you asked whether MHRA can
confirm whether we have “considered the matter o...
MHRA staff working on COVID-19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held.
Internal Review of FOI 21/751
Dear Kenneth MacArthur,
As requested, we have conducted an Internal Review of FOI 21/751.
We confirm th...
Dear Kenneth MacArthur,
Please find attached our response to your request for an Internal Review
(reference IR2021/07849).
Yours sincerely,
FOI...
Immune system's response to pathogens following COVID-19 vaccination
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Refused.
Internal Review of FOI 21/550
Dear Mr MacArthur,
Unfortunately, due to the number of Freedom of Information (FOI) requests
we have been re...
This person's 1 annotation
E-mails relating to Novavax COVID-19 vaccine
Request to Medicines and Healthcare Products Regulatory Agency by Kenneth MacArthur. Annotated by Kenneth MacArthur on .
Refused.
Response provided here: https://www.whatdotheyknow.com/request/e_mails_relating_to_pfizer_biont#incoming-1929858